Mature overall survival results of the INAVO120 trial were presented in a press conference for the American Society of ...

CHICAGO -- Adding the PI3K-pathway inhibitor inavolisib (Itovebi) to palbociclib (Ibrance) and fulvestrant significantly ...

The findings add to other research showing a lower risk of obesity-related cancers in patients taking GLP-1 drugs, a class of ...

ZoomRx polled 50 experienced oncologists and hemato-oncologists about 20 cancer drugmakers, asking the doctors to rank the ...

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

Roche's Itovebi was the first PI3K inhibitor to get approved as a first-line treatment for breast cancer last year – and new ...

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | ...

Tumors with low- and ultra-low levels of a protein called HER2 are treatable with Enhertu, but harder to identify. New ...

When Stephen Wright asked AI which UK shares he should take a look at, the number one choice is a stock that wasn’t even on ...

The winners of the RIBA East Awards 2025 were unveiled at a ceremony on 15 May, at which Young’s Court Development at ...

The Trust Hospital has called for better access to inhale medications for asthma patients in Ghana. Dr. Juliana Oye Ameh, Chief Executive Officer of Trust Hospital, described asthma as a pressing ...

Geoffrey Porges, a longtime biotech analyst and well-known Wall Street figure, stepped down as CFO of the New York biotech ...